Filing Flows › Onconetix (ONCO) › Q1 2026 › vs Q4 2025
Onconetix (ONCO) Q1 2026 vs Q4 2025 (quarter over quarter)
Onconetix's revenue fell $282K (-93%) from $304K in Q4 2025 to $21K in Q1 2026.
Onconetix, Q1 2026: revenue $21K (-79% year over year), net loss $4.2M, operating cash flow −$2.1M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $21K | $304K | −$282K | -93% |
| Other income, net | $6.0M | $7.0M | −$941K | -14% |
| Net loss | $4.2M | −$5.7M | $9.9M | — |
| Costs & expenses | $10.2M | $7.3M | $3.0M | +41% |
| Operating costs | $10.2M | $1.6M | $8.7M | +547% |
| SG&A | $2.0M | $1.5M | $535K | +36% |
| Other operating costs | $8.2M | $24K | $8.2M | 337× |
| Operating cash sources | $4.2M | −$5.7M | $9.9M | — |
| Depreciation & amortization | $5K | $3K | $2K | +62% |
| Share-based compensation | $22K | $4K | $18K | +427% |
| Working capital & other | $2.1M | −$8.8M | $10.8M | — |
| Cash used in operations | $2.1M | $3.1M | −$969K | -31% |
| Net loss absorbed | $4.2M | −$5.7M | $9.9M | — |
Questions
How much did Onconetix's revenue grow quarter over quarter in Q1 2026?
Onconetix's revenue fell $282K (-93%) from $304K in Q4 2025 to $21K in Q1 2026.